TOP STORIES

• REGULATORY CEFP Social Security Working Group Raises Questions on Price Maintenance Premium, Biosimilar Policy
  April 12, 2017

• COMMENTARY “Cash-and-Carry Dealers” and Their Peculiar Business Practices in the Spotlight in Wake of Counterfeit Harvoni Scandal
  April 12, 2017

• ORGANIZATION JGA Fires Back at Criticism on “Excessive” and “Expensive” Generics, Says No. of Makers Not So Many
  April 11, 2017

• TRENDS Astellas’ LLP Sale to Private Equity Group Signals New Business Model for Older Drugs
  April 10, 2017

• BUSINESS Boehringer Japan to Spur Joint Drug Discovery Research, Eyes 1st Clinical Trial in 2020
  April 7, 2017

• BUSINESS Actelion’s Flolan Generic Outstrips Originator in Pediatric Use with Rare Dosage Nod; Japan Chief Says Company Fulfilling Maker’s Responsibility
  April 6, 2017

• INTERVIEW Scohia Wants to Make Its “Carve Out” a Success Model for Japan Makers: CEO
  April 5, 2017

• REGULATORY “I Don’t Use Biosimilars,” Says Ex-Chief of Japan College of Rheumatology
  April 5, 2017

• REGULATORY MHLW Sets Up Office for Startup Support, Starts Receiving Applications for Consultations
  April 4, 2017

• BUSINESS EA Pharma Eager to Roll Out Several New Drugs in Next Couple of Years
  April 3, 2017

• TRENDS Mitsubishi Tanabe’s Exit Shows Research-Driven Makers’ Generic Biz at Crossroads
  March 31, 2017

• BUSINESS Tokyo Prosecutors File Appeal in Diovan Case
  March 30, 2017

• BUSINESS Mitsubishi Tanabe to Pull Plug on Generics, Transfer Biz to Nipro in October
  March 29, 2017

• ORGANIZATION Wholesalers to Address Product Return Issue after Fake Harvoni Case: JPWA Chair
  March 28, 2017

• ORGANIZATION Vaccine Association to Standardize Presentation of Expiration Dates above Inspection Dates on Outer Packaging
  March 27, 2017

• BUSINESS Wholesale Dealer President Deeply Sorry for Letting Fake Harvoni into Supply Chain
  March 24, 2017

• TRENDS As Takeda’s R&D Rejig Progresses, Biotech JV Launch Sets Direction for Its Japan Regime
  March 23, 2017

• BUSINESS Japan Begins Using PD-L1 Expression Biomarker for Immune Checkpoint Inhibitors, but Challenges Linger
  March 22, 2017

• ORGANIZATION Study Group Presents Proposal for Future Vision for Kampo Medicines
  March 21, 2017

• BUSINESS Court Finds Data Manipulation, but Not False Advertising: Diovan Case
  March 17, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 157
• 158
• 159
• 160
• 161
• 162
• 163
• 164
• 165
• …
• Next ›
• 最終 »